ArticleBMC infectious diseases2025
Epidemiology of respiratory syncytial virus and its subtypes among cases of influenza like illness and severe acute respiratory infection: findings from nationwide sentinel surveillance in Ethiopia.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A comprehensive look at Respiratory Syncytial Virus (RSV): from pathogenesis to prevention.Tropical diseases, travel medicine and vaccines · 2026Review
- Epidemiology and subtype analysis of respiratory syncytial virus among hospitalized children under five in Isfahan during early 2024.Iranian journal of microbiology · 2026Article
- The prevalence and role of human respiratory syncytial virus in pediatric respiratory tract infections: a systematic review and meta-analysis of global data.EClinicalMedicine · 2026Article
- Evaluation of Flu A/B, SARS-CoV-2, and RSV Antigen Combo Rapid Test in Hospitalized Children Under Two Years of Age.Diagnostics (Basel, Switzerland) · 2026Article
- Molecular and seroepidemiology of SARS-CoV-2 among influenza-like illness and severe Acute respiratory illness cases in selected health facilities in Ethiopia.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundData in Ethiopia on the epidemiology of Respiratory Syncytial Virus (RSV) and subtypes among influenza-like illness (ILI) and severe acute respiratory infections (SARI) cases is limited. Here, we assessed the epidemiology of RSV and its subtypes among the pediatric and adult ILI /SARI cases in Ethiopia.
methodsWe conducted prospective, multicenter facility-based study from May 2023 to April 2024. Respiratory swab specimens, epidemiological and clinical data were collected from participants of all age groups, and both hospitalized and non-hospitalized individuals who met the World Health Organization (WHO) case definition for ILI/SARI and provided informed consent. Laboratory investigation was performed using reverse transcription polymerase chain reaction (RT-PCR). Data were analyzed using SPSS V29. Descriptive statistics were used to summarize frequencies and ratios, and multivariable logistic regression model was employed to assess factors associated with RSV positivity.
resultsIn total, 4170 participants were enrolled, the majority (57.9%) of whom were cases from children under five and SARI (76.5%). RSV was detected in 654 cases (15.7%; 95% CI: 14.6-16.8). RSV subtyping was carried out for 475 (72.6%) of 654 RSV positive samples. The finding revealed that both RSV-A and RSV-B subtypes were co-circulating in Ethiopia, with predominance of RSV-B (68.8%). Age group, season and timing of sample collection were factors independently associated with RSV positivity. Accordingly, children aged < 2 years (AOR: 8.20, 95% CI: 3.57-18.81) and 2-4 years (AOR: 5.01, 95% CI: 2.15-11.67), autumn (AOR: 5.89, 95% CI: 3.79-9.17) and winter (AOR: 3.27, 95% CI: 2.07-5.16) seasons, and case whose samples were collected within three days of symptom onset (AOR: 1.76, 95% CI: 1.09-2.84) were significantly associated with RSV positivity.
conclusionsThe study provides evidence of RSV circulation among ILI/SARI cases in Ethiopia. It also revealed that RSV-B was the predominant subtype circulating in the country. The age-specific and temporal patterns of RSV positivity identified in this study contribute to the understanding of RSV and its subtypes epidemiology in Ethiopia. The findings provide valuable evidence to inform implementation of RSV vaccine introduction programs, particularly targeting high-risk populations during periods of peak transmission. Future research focusing on RSV genomic analysis and disease burden is needed to better understand RSV viral evolution, transmission dynamics and public health impacts in Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.